From natural-extract variability to reproducible nanomaterials: AI-QbD strategies for green synthesis from agro-food waste

Green synthesis of metal nanoparticles from agro-food waste extracts offers environmental and economic advantages over conventional chemical methods, using natural phytochemicals as reducing and stabilizing agents. However, inherent variability in botanical feedstocks, arising from seasonal fluctuation, geographic origin, and extraction protocols, poses significant challenges to reproducibility and standardization. Current literature documents fewer than 300 systematically characterized synthesis studies using non-harmonized protocols, and botanical extract composition inherently varies 15–30 % seasonally and geographically, limiting the generalization of process parameters across waste sources. This review critically examines the materials science foundations of phytochemical-mediated nanoparticle formation, including the mechanistic roles of phenolic compounds, flavonoids, and terpenoids in metal-ion reduction, nucleation kinetics, and surface capping. We analyze how feedstock composition and extraction conditions influence particle size distribution, morphology, crystallinity, and surface chemistry properties, which ultimately determine biological identity and functional performance. We then evaluate the potential of Quality-by-Design (QbD) frameworks and artificial intelligence (AI) approaches to address these reproducibility challenges. However, we emphasize that significant prerequisites remain before AI deployment is viable: AI model performance reported in the literature ranges from 65 to 85 % accuracy across heterogeneous botanical waste sources, substantially lower than idealized estimates, and current models suffer from dataset-size limitations and the risk of overfitting. We propose a phased implementation roadmap: Phase 1 (18–24 months) requires establishing harmonized botanical characterization protocols and controlled extraction procedures; Phase 2 requires 300–500 documented synthesis experiments across multiple waste sources; Phase 3 can then build predictive AI models on this standardized foundation. Throughout, we distinguish between demonstrated evidence, emerging proof-of-concept results, and areas requiring substantial further validation before clinical or industrial translation becomes feasible.